Brilacidin (PMX-30063) Actively ruptures the bacterial cell membrane structures in gramnegative enteric bacteria [17].
17. Boucher HW, Talbot GH, Benjamin DK, Bradley J, Guidos RJ, et al. (2013) 10×'20 progress-development of new drugs active against gramnegative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis 56: 1685-1694.